Inhibition of p300/CBP Suppresses Castration-Resistant Prostate Cancer [Drug Discovery]

A virtual ligand screen led to generation of A-485, a potent selective p300/CBP catalytic inhibitor.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: Drug Discovery Source Type: research